Siemens Healthineers AG

Business Alignment Public Company Limited, or BIZ, extended its congratulations on the occasion of Siriraj Hospital unveiling Asia's first Halcyon Version 5 radiotherapy machine. Chief Executive Officer Sompong Chuenkittiyanont and Assistant Chief Executive Officer for Finance and Human Resources Phuwit Silaphusit, together with a delegation of executives, attended the event. Professor Dr. Apichat Asavamongkolkul, Dean of the Faculty of Medicine Siriraj Hospital, Mahidol University, presided over the ceremony, and Professor Dr. Yongyut Sirivatanauksorn, Director of Siriraj Hospital, joined the press conference and the signing of a cooperation agreement between the Faculty of Medicine Siriraj Hospital and Siemens Healthineers. The Department of Radiology at the Faculty of Medicine Siriraj Hospital has adopted the Halcyon Version 5 radiotherapy machine to treat cancer and tumors with radiation therapy, making it the first in Asia. Its special features are revolutionary for the field of radiation therapy: faster speed, greater precision, and an improved patient experience. The event was held at the Roj Suwannasut Conference Room, Radiology Ratchanakharin Building, 2nd Floor, Siriraj Hospital.

MarketsandMarkets projects the global MRI systems market will grow from USD 6.88 billion in 2026 to USD 9.68 billion by 2031, at a CAGR of 7.0%. Growth is driven by the rising prevalence of neurological and musculoskeletal disorders, an expanding geriatric population, increasing chronic diseases like cancer, and supportive regulatory and reimbursement policies. The closed MRI systems segment held the largest market share in 2025, as did the fixed/stationary design segment. Asia Pacific is experiencing rapid growth, particularly in China, India, and Southeast Asia. Key players include Siemens Healthineers, GE HealthCare, Philips, FUJIFILM, and Canon, with innovations focusing on AI-enabled workflows and helium-free systems.

The global cardiovascular ultrasound system market is projected to grow from $1.73 billion in 2025 to $1.89 billion in 2026, a compound annual growth rate of 9.8%, and is forecast to reach $2.77 billion by 2030 at a CAGR of 10%, according to a new report from ResearchAndMarkets.com. Growth is driven by rising cardiovascular disease prevalence, demand for early non-invasive diagnostics, and adoption of AI-assisted imaging and portable devices. North America was the largest market in 2025, while Asia-Pacific is expected to be the fastest-growing region. Key developments include Royal Philips' August 2025 launch of Transcend Plus for its EPIQ CVx and Affiniti CVx systems, featuring FDA-cleared AI, and Philips' May 2023 acquisition of DiA Imaging Analysis for approximately $100 million to bolster AI-driven cardiac analysis. The report profiles major players including GE HealthCare, Siemens Healthineers, and Koninklijke Philips.

A new Siemens Healthineers report finds that delays before patients reach stroke centers remain a major barrier to timely treatment across Southeast Asia. The report, Strengthening Stroke System Readiness Across ASEAN, was released at Hospital Management Asia 2026 in Bangkok and draws on insights from seven experts across Indonesia, Malaysia, the Philippines, Singapore, Thailand, and Vietnam. It identifies transportation delays, slow reporting processes, limited government funding, weak inter-hospital coordination, reimbursement gaps, and workforce shortages as key obstacles. The experts highlight successful models such as Singapore's coordinated emergency services, Indonesia's hub-and-spoke system, Vietnam's public-private Stroke International Services, Thailand's Mobile Stroke Unit, and Malaysia's multidisciplinary teams. They also emphasize the potential of AI and tele-stroke technologies to improve diagnosis and coordination, and outline five priorities including strengthening referral pathways, reducing door-to-treatment times, investing in workforce, accelerating AI adoption, and improving public recognition of stroke warning signs.

The global AI in medical imaging market is projected to grow from USD 2.9 billion in 2025 to USD 19.4 billion by 2035, at a compound annual growth rate of 20.9%, according to a new report by Healthcare Foresights. The market is expected to reach USD 3.5 billion in 2026, driven by a shortage of radiologists, high imaging volumes, and the need for faster clinical decision-making. Key growth factors include advancements in deep learning algorithms, increasing adoption of digital health technologies, and supportive regulatory approvals for AI-powered tools. North America is forecast to grow at a CAGR of 16.7%, while the Asia Pacific region is experiencing the highest growth due to rapid digital health transformation and expanding medical imaging infrastructure. Prominent players in the market include GE HealthCare Technologies, Siemens Healthineers, Koninklijke Philips, and Canon Medical Systems.

Siemens Healthineers raised its fiscal 2026 adjusted earnings per share forecast while lowering its comparable revenue growth outlook. The company now expects adjusted basic earnings per share between €2.35 and €2.45, up from the prior range of €2.20 to €2.30, and comparable revenue growth of 3.5 percent to 4.0 percent, down from 4.5 percent to 5.0 percent. The revision reflects the performance of the Diagnostics segment and the impact of tariff refunds under the U.S. International Emergency Economic Powers Act. Third-quarter net income rose to €669 million from €552 million a year earlier, with adjusted EBIT climbing 15.6 percent to €1.101 billion and revenue increasing 1.8 percent to €5.764 billion.

A new survey commissioned by Siemens Healthineers and conducted by YouGov finds that 82% of U.S. healthcare executives considered expanding their laboratory services in the past year, and 54% are prioritizing diagnostic and lab equipment upgrades, second only to AI tools. The findings, released at the ADLM 2026 Annual Scientific Meeting, show that 81% of the 155 surveyed executives strongly agree lab turnaround times directly affect patient care, and 72% strongly agree lab performance is critical to wider organizational efficiency. However, the survey also reveals that 31% of executives whose lab investment considerations stalled cited uncertainty about the cost-benefit proposition as the primary reason, highlighting an opportunity to make clearer business cases for laboratory modernization.

The global radiotherapy market is projected to grow from USD 7.98 billion in 2026 to USD 10.68 billion by 2031, at a CAGR of 6.0%, according to a new report by MarketsandMarkets. Growth is driven by rising cancer incidence, increased healthcare investments, and demand for precision oncology, with rapid adoption of technologies such as proton beam therapy, adaptive radiotherapy, and AI-based treatment planning. The systems segment is expected to hold the largest share, while external beam radiotherapy dominates across technology, application, and procedure segments, and hospitals remain the leading end user. Asia Pacific is forecast to register the highest CAGR, supported by expanding oncology infrastructure and government spending in countries including China, India, and Japan. Key players include Siemens Healthineers AG, Elekta, Accuray Incorporated, IBA Worldwide, and ViewRay Technologies.

United Imaging Intelligence, an AI-focused subsidiary of Chinese medical technology giant Shanghai United Imaging Healthcare, is taking a cautious approach to deploying AI tools, resisting pressure for an aggressive rollout. Co-CEO Zhou Xiang, speaking on the sidelines of the World Artificial Intelligence Conference, said the company is not that extreme, noting that software engineers and architects warned him about potential side effects because the technology remains insufficiently mature. He added that in healthcare and medicine, the first mover advantage is not as drastic as in other fields. The United Imaging group competes with GE HealthCare, Siemens Healthineers and Philips in medical imaging and scanning equipment.

The global AI in ultrasound imaging market is projected to grow from $1.28 billion in 2025 to $2.23 billion by 2030, at a compound annual growth rate of 11.8%. This growth is driven by increasing demand for point-of-care diagnostics, advancements in machine learning algorithms, and the rising prevalence of cancer. Key players include Samsung Electronics, Intel Corporation, IBM, NVIDIA, and Siemens Healthineers, which launched the portable AI-powered Acuson Maple system in November 2023. GE HealthCare strengthened its ultrasound offerings through the acquisition of Caption Health in February 2023. North America led the market in 2025, while Asia-Pacific is expected to witness the fastest growth during the forecast period.

Investment in artificial intelligence for the medical plastics market surged past $2.3 billion in 2024, according to BCC Research. BASF led the spending with a $1.1 billion research and development commitment to AI reactor technology. The European Commission approved $471 million in public funding for medical device AI innovation, while Siemens Healthineers secured a $560 million AI deal with the Canadian government. Key players including Medtronic, Johnson & Johnson, Abbott Laboratories, and Boston Scientific are also driving AI integration to enhance manufacturing precision and quality control.

The Fourth China International Supply Chain Expo has opened its Healthy Life Chain section, drawing more than 100 leading companies across Medical Technology, Quality Living, and Heritage Wellness zones. Global players GE Healthcare and Siemens Healthineers are demonstrating full China-for-China R&D and manufacturing capabilities, while AstraZeneca features an AI-powered drug discovery platform. Chinese innovators including BGI with a human genome foundation model and Longwood Valley with a domestically produced orthopedic surgical robot are also taking center stage. In consumer health, Procter & Gamble, L'Oréal, Panasonic, and Starbucks are showcasing digital intelligence and sustainability in their supply chains, with Starbucks connecting directly to Yunnan coffee farms for full traceability. Chinese TCM brands such as Guangzhou Phar. Holdings, Xin Bao Tang, and Zhendong Pharmaceutical are accelerating global expansion and vertical integration of authentic herb supply chains, alongside AI-driven diagnostic tools like smart pulse-taking devices.

NVIDIA has released NVIDIA XR AI in public beta, a framework for building multimodal AI agents for AR glasses and XR devices. The release extends NVIDIA's AI infrastructure beyond hyperscale training clusters into edge and physical AI, connecting XR device inputs with models, enterprise data, tools, and accelerated computing. It integrates services such as Metropolis, NeMo Retriever, Nemotron, Cosmos Reason, and DGX/RTX PRO systems. Early use cases include Siemens factory maintenance research, lab workflows from Rana's LabOS, and surgical-assistance work at UPMC. NVIDIA reported fiscal Q1 2027 revenue of $81.6 billion, up 85% year-over-year, with data center revenue rising 92% to $75.2 billion.

The global healthcare command centers market is projected to grow from USD 1.8 billion in 2024 to USD 5.0 billion by 2034, at a compound annual growth rate of 10.8%, according to a new report from Zion Market Research. The software component segment held a 48% share in 2024, while the cloud-based deployment mode accounted for 49% of the market. North America led with a 41% share, driven by advanced healthcare infrastructure and technology adoption. Key players include GE HealthCare, Koninklijke Philips N.V., Siemens Healthineers, and Oracle (Cerner).